Publicaciones en las que colabora con EDUARDO FERNÁNDEZ-CRUZ PÉREZ (36)

2022

  1. Evolution and molecular interactions of major histocompatibility complex (MHC)-G, -E and -F genes

    Cellular and Molecular Life Sciences, Vol. 79, Núm. 8

  2. HLA-G: Too Much or Too Little? Role in Cancer and Autoimmune Disease

    Frontiers in Immunology, Vol. 13

2021

  1. HLA-G 3’UTR Polymorphisms Are Linked to Susceptibility and Survival in Spanish Gastric Adenocarcinoma Patients

    Frontiers in Immunology, Vol. 12

2016

  1. Multicenter study for the evaluation of the antibody response against salmonella typhi Vi vaccination (EMPATHY) for the diagnosis of Anti-polysaccharide antibody production deficiency in patients with primary immunodeficiency

    Clinical Immunology, Vol. 169, pp. 80-84

2014

  1. Experience in IVIg therapy for selected women with recurrent reproductive failure and NK cell expansion

    American Journal of Reproductive Immunology, Vol. 71, Núm. 5, pp. 458-466

2013

  1. New decision-tree model for defining the risk of reproductive failure

    American Journal of Reproductive Immunology, Vol. 70, Núm. 1, pp. 59-68

  2. Sequential combined therapy with Omalizumab and Rituximab: A new approach to severe atopic dermatitis

    Journal of Investigational Allergology and Clinical Immunology, Vol. 23, Núm. 3, pp. 190-196

2012

  1. Intravenous Immunoglobulin Treatment Increased Live Birth Rate in a Spanish Cohort of Women with Recurrent Reproductive Failure and Expanded CD56 + Cells

    American Journal of Reproductive Immunology, Vol. 68, Núm. 1, pp. 75-84

  2. Long-term decrease in VLA-4 expression and functional impairment of dendritic cells during natalizumab therapy in patients with multiple sclerosis

    PLoS ONE, Vol. 7, Núm. 4

2011

  1. A leaky mutation in CD3D differentially affects αβ and γδ T cells and leads to a Tαβ- Tγδ + B + NK + human SCID

    Journal of Clinical Investigation, Vol. 121, Núm. 10, pp. 3872-3876

  2. Alopecia universal en un adulto tras la vacunación de rutina con toxoide tetánico

    Medicina Clinica

  3. Estradiol-dependent perforin expression by human regulatory T-cells

    European Journal of Clinical Investigation, Vol. 41, Núm. 4, pp. 357-364

  4. Sublingual therapeutic immunization with a polyvalent bacterial preparation in patients with recurrent respiratory infections: Immunomodulatory effect on antigen-specific memory CD4+ T cells and impact on clinical outcome

    Clinical and Experimental Immunology, Vol. 164, Núm. 1, pp. 100-107

2010

  1. IFNβ-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: A longitudinal 1-year study

    Clinical Immunology, Vol. 134, Núm. 2, pp. 148-157

  2. Long-term remission of severe refractory dermatopolymyositis with a weekly-scheme of immunoglobulin followed by rituximab therapy

    Rheumatology International, Vol. 30, Núm. 6, pp. 817-819

  3. Severe refractory hidradenitis suppurativa in an HIV-positive patient successfully treated with infliximab

    Archives of Dermatology, Vol. 146, Núm. 12, pp. 1343-1345

2009

  1. Clinical response to interferon-β-1a may be linked to low baseline circulating BDCA1 myeloid dendritic cells. Differential role of circulating dendritic cells and CD4+ regulatory T-cells in relapsing-remitting multiple sclerosis: A 1-year longitudinal study

    Journal of Neuroimmunology, Vol. 212, Núm. 1-2, pp. 112-120

  2. NK cell expansion in obstetrical antiphospholipid syndrome: Guilty by association?

    European Journal of Obstetrics and Gynecology and Reproductive Biology

2008

  1. Eczematous dermatitis in the setting of hyper-IgE syndrome successfully treated with omalizumab

    Archives of Dermatology

  2. Expansion of regulatory CD8+ T-lymphocytes and fall of activated CD8+ T-lymphocytes after iv methyl-prednisolone for multiple sclerosis relapse

    Journal of Neuroimmunology, Vol. 204, Núm. 1-2, pp. 131-135